000 01592nam a2200325 a 4500
001 ebr10740178
003 CaPaEBR
006 m o u
007 cr cn|||||||||
008 130222s2013 enkad sb 001 0 eng d
010 _z 2013006115
020 _z9781409448273 (hardcover : alk. paper)
020 _z9781409448280 (e-book)
040 _aCaPaEBR
_cCaPaEBR
035 _a(OCoLC)855022848
050 1 4 _aHD9665.5
_b.A574 2013eb
082 0 4 _a338.4/76151
_223
100 1 _aAnsell, John,
_d1947-
245 1 0 _aTransforming big pharma
_h[electronic resource] :
_bassessing the strategic alternatives /
_cJohn Ansell.
260 _aFarnham, Surrey :
_bGower Pub. Ltd.,
_c2013.
300 _axvi, 265 p. :
_bill.
504 _aIncludes bibliographical references and index.
505 0 _apt. I. How pharma differs and why this is important -- pt. II. Assessing management concepts for the pharmaceutical industry -- pt. III. Big pharma's strategic options -- pt. IV. Where will new products come from? -- pt. V. Prospects for new products -- pt. VI. Getting a true fix on prospects -- pt. VII. Conclusions and summary.
533 _aElectronic reproduction.
_bPalo Alto, Calif. :
_cebrary,
_d2013.
_nAvailable via World Wide Web.
_nAccess may be limited to ebrary affiliated libraries.
650 0 _aPharmaceutical industry
_xManagement.
650 0 _aStrategic planning.
655 7 _aElectronic books.
_2local
710 2 _aebrary, Inc.
856 4 0 _uhttp://site.ebrary.com/lib/rucke/Doc?id=10740178
_zAn electronic book accessible through the World Wide Web; click to view
999 _c35299
_d35299